Allworth Financial’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-816
Closed -$34.9K 3365
2023
Q1
$34.9K Hold
816
﹤0.01% 1210
2022
Q4
$38.6K Hold
816
﹤0.01% 1115
2022
Q3
$31K Hold
816
﹤0.01% 1128
2022
Q2
$36K Hold
816
﹤0.01% 1013
2022
Q1
$42K Hold
816
﹤0.01% 956
2021
Q4
$46K Hold
816
﹤0.01% 866
2021
Q3
$39K Hold
816
﹤0.01% 843
2021
Q2
$38K Hold
816
﹤0.01% 688
2021
Q1
$33K Buy
+816
New +$32.2K ﹤0.01% 666

Other funds holding RXL

Allworth Financial's RXL Position: Q2 2023 in Review

Allworth Financial sold out of ProShares Ultra Health Care (RXL) in Q2 2023, closing a stake of 816 shares — an estimated $34.9K sold.

Allworth Financial first reported a position in RXL in Q1 2021 and held it in 9 quarters. The position peaked at $46K in Q4 2021. 17 funds tracked by Wall St. Rank hold RXL as of Q2 2023.

  • Allworth Financial reported no remaining ProShares Ultra Health Care position as of Q2 2023 after selling out during the quarter.
  • Allworth Financial sold 816 ProShares Ultra Health Care shares in Q2 2023, an estimated $34.9K.
  • Allworth Financial first reported a position in ProShares Ultra Health Care in Q1 2021 and held it in 9 quarters.
  • Allworth Financial's ProShares Ultra Health Care position peaked at $46K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2023.

Based on Allworth Financial's 13F filing for Q2 2023, filed 18 Jul 2023.